Prepared by Yoon Hang Kim, MD, MPH

Introduction

The client’s child is autistic and nonverbal, presenting with prolonged nighttime crying episodes (approximately two hours nightly) and frequent daytime crying. Because the child cannot verbally communicate the source of distress, this evaluation aims to systematically identify any underlying medical, gastrointestinal, nutritional, sensory, sleep-related, or metabolic contributors. The family has already implemented comfort and calming strategies, including autism-friendly toys, sensory tools, familiar routines, and environmental modifications, but symptoms persist.

Client’s Desired Outcomes

• Root Cause Identification: Determine whether medical, gastrointestinal, nutritional, sensory, or sleep-related issues are driving the child’s distress.
• Improved Sleep and Comfort: Help the child sleep through the night, wake calmer, and reduce the frequency and intensity of crying episodes.
• Enhanced Quality of Life and Development: Address underlying contributors so the child can be more comfortable, regulated, engaged, and able to reach full potential.

Part I: Conventional Medicine Baseline Evaluation

Standard evaluations for autism spectrum disorder (ASD) typically emphasize behavioral and developmental assessments. These confirm the diagnosis and characterize strengths and challenges but do not routinely address underlying medical contributors to symptoms like persistent crying and sleep disruption in nonverbal individuals. The following conventional workup establishes a clinical baseline.

1. History and Physical Examination

A thorough history and physical examination is the essential first step and should include the following areas of focus:

• Detailed dietary history, including selective eating patterns (extremely common in ASD), food texture preferences and aversions, and caloric adequacy.
• Bowel pattern review: frequency, consistency (Bristol Stool Scale), straining, incomplete evacuation, visible blood or mucus.
• Feeding and swallowing assessment: any signs of dysphagia, choking, or oral-motor difficulty.
• Medication review: current and prior medications, supplements, and any temporal relationship between medication changes and symptom onset.
• Pain behavior assessment: subtle signs of pain in nonverbal individuals, including arching, grimacing, pressing abdomen against furniture, teeth grinding (bruxism), pulling at ears, self-injurious behavior, and changes in posture or positioning.
• Sleep history: bedtime routine, sleep onset latency, nocturnal awakenings (frequency, duration, character), snoring, gasping, mouth breathing, restless movements, sleep position, and total sleep duration.
• Environmental and sensory review: lighting, noise, temperature, bedding textures, and any recent environmental changes.
• Developmental and behavioral baseline: communication modalities, adaptive function, any regression or loss of previously acquired skills.

2. Standard Laboratory Evaluation

These baseline labs are typically ordered through conventional channels and help rule out common medical contributors:

3. Conventional Specialist Referrals

• Pediatric Gastroenterology: If history or baseline labs suggest GI pathology. Consider upper/lower endoscopy if empiric treatment fails or red flags are present (weight loss, blood in stool, persistent vomiting).
• Sleep Medicine / Polysomnography: To rule out obstructive sleep apnea (common in ASD), restless legs syndrome / periodic limb movement disorder, parasomnias, or other primary sleep disorders contributing to nighttime awakenings.
• Pediatric Neurology: Consider if there is any concern for seizures (nocturnal seizures can present as unexplained awakenings with crying), regression, or focal neurological findings. EEG with overnight monitoring may be indicated.
• ENT / Adenotonsillar Evaluation: If snoring, mouth breathing, or airway obstruction signs are present.
• Pediatric Dentistry: Dental pain is a frequently overlooked cause of unexplained crying in nonverbal children. Comprehensive dental evaluation including assessment for caries, abscesses, eruption issues, and bruxism-related pain.

Part II: Functional Medicine Extended Evaluation

The functional medicine approach moves beyond ruling out disease to identifying root-cause contributors to the child’s symptoms. In nonverbal autistic children, irritability and sleep disturbance frequently have identifiable, treatable physiological drivers. The following categories represent the most clinically relevant functional medicine testing.

4. Gastrointestinal Deep Dive

GI dysfunction is one of the most common and most impactful comorbidities in ASD. Prevalence estimates range from 24% to 79% depending on the study population and definitions used. In nonverbal children, GI distress frequently manifests as behavioral changes, sleep disruption, and crying rather than verbal complaints of abdominal pain.

Comprehensive Stool Analysis

• GI-MAP (Diagnostic Solutions) or Doctor’s Data Comprehensive Stool Analysis with Parasitology.
• Key markers: commensal and pathogenic bacteria (including Clostridioides difficile, H. pylori), yeast/fungal overgrowth (Candida species and others), parasitology, viral markers.
• Digestive function markers: pancreatic elastase, fecal fat (steatocrit).
• Inflammation: fecal calprotectin (mucosal inflammation), secretory IgA (mucosal immune function), lactoferrin.
• Zonulin: marker of intestinal permeability (“leaky gut”); elevated levels correlate with systemic inflammation and have been specifically studied in ASD populations.

Additional GI Considerations

• SIBO breath testing (lactulose or glucose substrate) if symptoms suggest small intestinal bacterial overgrowth (bloating, distension, alternating stool patterns).
• Empiric constipation management: many nonverbal children with ASD have functional constipation that is underdiagnosed; an abdominal X-ray can reveal fecal loading even when external stool patterns appear normal.
• Gastroesophageal reflux assessment: clinical trial of acid suppression if symptoms are suggestive (arching during/after meals, nighttime awakenings with crying, food refusal).

5. Nutritional and Metabolic Assessment

Nutritional deficiencies are exceptionally common in autistic children due to selective eating patterns, restricted diets, and potential malabsorption. These deficiencies can directly contribute to sleep disturbance, irritability, and neurological symptoms.

Comprehensive Nutrient Panel

• Vitamin D (25-OH): frequently deficient in ASD; critical for immune modulation, sleep regulation, and mood. Target: 50–80 ng/mL.
• Magnesium (RBC magnesium preferred over serum): essential for sleep, muscle relaxation, and neurological function. Serum magnesium is a poor indicator of total body stores.
• Zinc (plasma or RBC): important for immune function, gut integrity, neurotransmitter synthesis, and taste/appetite regulation.
• B vitamins: B12 (methylmalonic acid for functional assessment), folate (consider MTHFR-related methylation issues), B6.
• Omega-3 fatty acids (EPA/DHA): anti-inflammatory; deficiency linked to behavioral and cognitive symptoms.
• Copper-to-zinc ratio: imbalances are reported in some ASD studies and may contribute to oxidative stress and behavioral symptoms.
• Amino acid profile (plasma): can reveal protein malnutrition, neurotransmitter precursor deficiencies, and metabolic abnormalities.

Organic Acids Test (OAT)

The OAT (Great Plains Laboratory / Mosaic Diagnostics) is a urine test that provides a comprehensive metabolic snapshot and is particularly valuable in the ASD population. Key domains evaluated include:

• Mitochondrial function markers (citric acid cycle intermediates): mitochondrial dysfunction is increasingly recognized in a subset of autistic individuals.
• Neurotransmitter metabolites: serotonin, dopamine, and norepinephrine pathway markers that may illuminate mood, sleep, and behavioral contributors.
• Gut dysbiosis markers: HPHPA (Clostridia metabolite), arabinose (Candida/yeast), DHPPA, and other microbial metabolites.
• Oxidative stress markers: evaluating glutathione status and oxidative burden.
• Vitamin and cofactor markers: functional indicators of B vitamin, CoQ10, and other nutrient status.

6. Food Sensitivity and Immune-Mediated Reactivity

Food sensitivities (distinct from IgE-mediated food allergies) are a common functional medicine consideration in ASD. Delayed immune reactions (IgG-mediated or cell-mediated) can contribute to GI inflammation, behavioral symptoms, and sleep disruption.

• IgG food sensitivity panel (e.g., Vibrant Wellness, US BioTek, Cyrex Array 10): provides a starting point, though clinical correlation and elimination/reintroduction trials are essential for validation.
• Gluten and casein evaluation: the gluten-free/casein-free (GFCF) diet has mixed evidence in ASD literature but is widely used clinically. Consider gluten-related cross-reactive foods (Cyrex Array 4) if indicated.
• Elimination diet: an empiric 4–6 week elimination of the most common triggers (gluten, dairy, soy, corn, eggs, artificial additives) with systematic reintroduction remains the gold standard for identifying dietary contributors.
• Histamine intolerance evaluation: if symptoms include flushing, GI distress, or episodic behavioral changes coinciding with high-histamine foods.

7. Sleep-Specific Functional Evaluation

Sleep disturbance affects 50–80% of autistic children and is one of the most significant quality-of-life concerns for families. In addition to the conventional polysomnography noted above, the functional medicine workup should include:

• Salivary melatonin profile (dim light melatonin onset, or DLMO): assesses circadian rhythm function. Melatonin synthesis abnormalities are well-documented in ASD.
• Salivary cortisol diurnal curve (4-point cortisol or DUTCH test): evaluates the hypothalamic-pituitary-adrenal (HPA) axis. Dysregulated cortisol patterns (elevated nighttime cortisol, flattened diurnal curve) can drive nighttime awakenings.
• Neurotransmitter metabolites (from OAT or urinary neurotransmitter testing): serotonin is the precursor to melatonin; impaired serotonin metabolism may contribute to both mood disturbance and sleep-onset/maintenance difficulties.
• Ferritin: even in the absence of frank anemia, low ferritin (<50 ng/mL) is associated with restless legs syndrome and periodic limb movements, both of which are more prevalent in ASD and can cause nighttime awakenings.

8. Environmental and Toxicant Screening

Environmental exposures should be evaluated based on clinical history, geographic risk, and symptom patterns.

• Heavy metals: blood lead (if not already obtained), blood mercury, urine toxic metals panel (provoked or unprovoked depending on clinical judgment). Hair tissue mineral analysis (HTMA) can serve as a screening tool.
• Mycotoxin screening (urine mycotoxins, e.g., RealTime Labs or Great Plains/Mosaic): if there is any history of water-damaged buildings, visible mold, or musty environments. Mycotoxin exposure can drive neuroinflammation, GI dysfunction, and sleep disturbance.
• Environmental pollutant exposure assessment: review of household products, cleaning agents, pesticide exposure, and water quality.

9. Immune and Inflammatory Deep Dive

Immune dysregulation and neuroinflammation are increasingly recognized as contributors in a subset of autistic individuals.

• Comprehensive immunoglobulin panel (IgG, IgA, IgM, IgE subclasses): evaluates immune competence and identifies potential immunodeficiency or overactivation.
• Cytokine panel (if available): elevated pro-inflammatory cytokines have been documented in some ASD populations.
• Autoimmune markers: consider anti-neuronal antibodies or related panels if there is a clinical suspicion of autoimmune encephalitis or PANS/PANDAS-spectrum presentation (particularly if symptom onset was acute or episodic).
• MTHFR and methylation-related SNPs: while not diagnostic in isolation, they can inform supplementation strategies (methylfolate vs. folinic acid, methylcobalamin dosing) and contextualize detoxification capacity.

Part III: Suggested Prioritization Strategy

Given the complexity and potential cost of a comprehensive workup, a stepwise approach is recommended. The following tiering reflects clinical yield, ease of collection (especially important in a nonverbal child), and potential for rapid actionable results.

Part IV: Integrating Results Into a Treatment Plan

Once testing is completed, results should be synthesized into an individualized treatment plan. Common intervention categories include:

• Gastrointestinal restoration: Targeted antimicrobial or antifungal therapy for identified pathogens, followed by probiotic repletion, digestive enzyme support, and intestinal permeability repair (L-glutamine, zinc carnosine, butyrate).
• Nutritional repletion: Targeted supplementation based on documented deficiencies, with dosing informed by age, weight, and severity. Prioritize bioavailable forms (methylcobalamin, methylfolate, magnesium glycinate/threonate, vitamin D3 with K2).
• Dietary modification: Guided by food sensitivity results and/or elimination diet findings. Implementation should be gradual and family-centered, with attention to maintaining caloric and nutritional adequacy in an already selective eater.
• Sleep optimization: Address identified sleep disorder (CPAP for apnea, iron repletion for restless legs). Melatonin supplementation (starting low, 0.5–1 mg, titrating as needed) is well-studied in ASD. Optimize sleep hygiene, cortisol regulation, and magnesium status.
• Environmental remediation: If toxicant exposure is identified, implement avoidance strategies and targeted detoxification support under clinical supervision.
• Continued behavioral and sensory support: Medical interventions complement, not replace, the behavioral strategies the family has already implemented. Occupational therapy, speech therapy, and ABA or developmental approaches should continue in parallel.

Multidisciplinary Collaboration

Optimal outcomes require coordination among the family, the integrative/functional medicine physician, and relevant specialists. Key collaborators may include a pediatric gastroenterologist, sleep medicine specialist, pediatric neurologist, pediatric dentist, occupational therapist, speech-language pathologist, and behavioral health professionals. The functional medicine physician serves as the integrative hub, synthesizing findings across disciplines and ensuring that interventions are coordinated, prioritized, and monitored.

About Dr. Kim

Dr. Yoon Hang “John” Kim is a board-certified Preventive Medicine physician with over 20 years of clinical experience. He completed his fellowship at the University of Arizona Andrew Weil Center for Integrative Medicine and holds certifications in preventive medicine, medical acupuncture (UCLA), and integrative/holistic medicine. He specializes in low-dose naltrexone (LDN), autoimmune conditions, chronic pain, integrative oncology, fibromyalgia, chronic fatigue syndrome, mast cell activation syndrome, and mold-related illness. Dr. Kim is the author of three books and more than 20 peer-reviewed articles.

Professional: www.yoonhangkim.com

Clinical: www.directintegrativecare.com